Research and Development
Novavax rides high on crest of RSV vaccine wave
August 12, 2015 Research and Development AbbVie, MedImmune, Novavax, RSV, vaccines
MedImmune and Inovio collaborate on cancer vaccine
August 11, 2015 Manufacturing and Production, Research and Development AstraZeneca, HPV, Inovio, MedImmune, cancer vaccines, cervical cancer, oncology
Aprecia boosts 3D printing facilities at new US site
August 11, 2015 Manufacturing and Production, Research and Development
UK medical innovation backed with £18m Biomedical Catalyst fund
August 10, 2015 Research and Development, Sales and Marketing
Sanofi, Evotec and Apeiron partner on immuno-oncology
August 10, 2015 Research and Development, Sales and Marketing Apeiron, Cancer, Evotec, Sanofi, immuno-oncology, immunotherapy, tumours
MedImmune and Mirati to partner on lung cancer combo
August 6, 2015 Research and Development AstraZeneca, Cancer, MedImmune, Mirati, Mirati Therapeutics, NSCLC, durvalumab, immuno-oncology, immunotherapy, lung cancer, mocetinostat
AstraZeneca buys rights to Heptares experimental cancer treatment
August 6, 2015 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, HTL-1071, immuno-oncology
Shire goes public with rejected $30bn Baxalta bid
August 5, 2015 Research and Development, Sales and Marketing Baxalta, Shire, acquisitions, baxter, mergers, rare disease
Lilly set for Cymbalta lawsuit showdown
August 5, 2015 Research and Development cymbalta, duloxetine, lawsuit, lilly
First 3D-printed drug approved by FDA
August 4, 2015 Manufacturing and Production, Research and Development 3d printing, FDA, manufacturing, production
Teva buys majority stake in genomic analysis firm
August 4, 2015 Manufacturing and Production, Research and Development, Sales and Marketing CNS, Immuneering, Teva, central nervous system, genetic analysis
Shire in $300m Foresight acquisition
August 4, 2015 Manufacturing and Production, Research and Development, Sales and Marketing FST-100, Foresight Biotherapeutics, Shire, conjunctivitis, dry eye, lifitegrast, pink eye
AstraZeneca and Isis Pharma in $65m drugs collaboration
August 3, 2015 Manufacturing and Production, Research and Development AstraZeneca, Isis Pharma, Isis Pharmaceuticals, antisense, drug R&D
Encouraging first results from trial of Merck’s Ebola vaccine
July 31, 2015 Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination
BMS to trial Opdivo in solid tumours
July 30, 2015 Research and Development BMS, Bristol-Myers Squibb, Kyowa Hakko Kirin, Poteligeo, mogamulizumab, nivolumab, opdivo, solid tumours
Latest content
MedPharm appoints Jason Mieding as chief operating officer
Coriolis Pharma appoints Teun van der Heide as CEO
